A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. by Alan Rigter, Ivy Widjaja, Hanneke Versantvoort, Frank E J Coenjaerts, Maarten van Roosmalen, Kees Leenhouts, Peter J M Rottier, Bert Jan Haijema, Cornelis A M de Haan

Get full text